12:00 AM
 | 
Dec 19, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Paladin sales and marketing update

Paladin launched DigiFab in Canada to treat digoxin toxicity or overdose. Health Canada approved the polyclonal antibody against...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >